Concepedia

Author

Fabrizia Corona

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Also Known As

Chiara Sandrin, Corona, Fabrizia, Daniel Álvarez de la Sierra, F Corona, F. Corona, FABRIZIA CORONA, Fabrizia Corona, Fatih Ozaltin, Kimberly Gilmour, Miroslav Harjacek

113

Publications

3.5K

Citations

27

H-Index

76

Concepts

All Affiliations

Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversity of MilanIstituto Giannina GasliniUniversity of PaduaMeyer Children's Hospital
FC

About

Fabrizia Corona is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in medicine, rheumatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

688

2

Allergy

2

2

248

3

Education

1

1

62

4

Engineering

1

1

23

5

Anatomy

1

1

16

Fabrizia Corona

×

39

Publications

3.2K

Citations

25

H-Index

YearCitations

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

Nicolino Ruperto, Kevin Murray, V. Gerloni,

Arthritis & Rheumatism

2004

372

Localized scleroderma in childhood is not just a skin disease

Francesco Zulian, Cristina Vallongo, Patricia Woo,

Arthritis & Rheumatism

2005

360

Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

Angelo Ravelli, Lucia Trail, Cristina Ferrari,

Arthritis Care & Research

2009

273

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Nicolino Ruperto, Angela Pistorio, Sheila Oliveira,

The Lancet

2015

224

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study

Maria Luisa Bianchi, Rolando Cimaz, M Bardare,

Arthritis & Rheumatism

2000

206

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

Maria Elisabetta Zannin, Carolina Birolo, V. Gerloni,

The Journal of Rheumatology

2012

154

Neutrophils from patients with <i>TNFRSF1A</i> mutations display resistance to tumor necrosis factor–induced apoptosis: Pathogenetic and clinical implications

Andrea D’Osualdo, Francesca Ferlito, Ignazia Prigione,

Arthritis & Rheumatism

2006

143

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Sergio Davì, Francesca Minoia, Angela Pistorio,

Arthritis & Rheumatology

2014

115

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier,

Annals of the Rheumatic Diseases

2018

106

Factors affecting survival in juvenile systemic sclerosis

Giorgia Martini, Fabio Vittadello, Özgür Kasapçopur,

Lara D. Veeken

2008

90

Page 1